Skip to main content

Table 3 Characteristics of patients with RPL in the external validation cohort

From: Investigation of the role of X chromosome inactivation and androgen receptor CAG repeat polymorphisms in patients with recurrent pregnancy loss: a prospective case–control study

 

RPL cohort

P-value*

N = 363

Age (years)

33.58 ± 4.64

NS

BMI

22.33 ± 1.48

NS

No. of pregnancy losses

3.21 ± 0.71

NS

E2 (pg/ml)

40.45 ± 20.05

NS

T (ng/dL)

44.69 ± 17.36

NS

Ovarian reserve

AMH

3.96 ± 3.60

NS

FSH on day 2

7.85 ± 2.63

NS

AFC

11.64 ± 6.85

NS

Cycle characteristics

Duration of stimulation

9.42 ± 2.48

NS

Total dosage of gonadotrophins

26.82 ± 11.59

NS

Estradiol on trigger day (pmol/l)

4236.62 ± 2270.31

NS

Mature oocytes (MII) retrieved

9.38 ± 6.09

NS

Fertilized oocytes (2PN)

8.36 ± 5.74

NS

No. of cleavage stage embryos

6.48 ± 4.64

NS

No. of blastocysts

3.11 ± 2.89

NS

No. of euploid blastocysts

1.86 ± 1.92

NS

No. of aneuploid blastocysts

1.31 ± 1.42

NS

No. of mosaic blastocysts

0.06 ± 0.23

NS

  1. *Comparison with patients in the RPL group